Adriana Castillo Chavez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adriana Castillo Chavez has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Zapata Sifuentes
Facultad de Ciencias Biologicas, Universidad Ricardo Palma, Lima, Peru
2 shared publications - Gianfranco Landa Bianchi
Facultad de Ciencias Biologicas, Universidad Ricardo Palma, Lima, Peru
2 shared publications - Roberto Pineda
Universidad Ricardo Palma
2 shared publications - Romina Garavito-Salini Casas
Facultad de Ciencias Biologicas, Universidad Ricardo Palma, Lima, Peru
2 shared publications - Santiago Justo Arevalo
Departamento de Bioquimica, Instituto de Quimica - Universidade de São Paulo, São Paulo, Brazil; Facultad de Ciencias Biologicas - Universidad Ricardo Palma, Santiago de Surco, Peru
2 shared publications - Anderson Oropeza
Laboratorio de Biotecnología y Fisiología Animal Biológicas - Escuela Académica de Biología Facultad de Ciencias Biológicas - Universidad Ricardo Palma (URP), Av. Benavides 5440 – Santiago de Surco, Lima, Perú
1 shared publication
Latest Publications
- Open Access
Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and High-Frequency mutation N501Y in different levels of control measures
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease has spread globally, causing more than 161.5 million cases and 3.3 million deaths to date. Surveillance and monitoring of new mutations in the virus’ genome are crucial to our understanding of the adaptation of SARS-CoV-2. Moreover, how the temporal dynamics of these mutations is influenced by control measures and non-pharmaceutical interventions (NPIs) is poorly understood. Using 1 058 020 SARS-CoV-2 from sequenced COVID-19 cases from 98 countries (totaling 714 country-month combinations), we perform a normalization by COVID-19 cases to calculate the relative frequency of SARS-CoV-2 mutations and explore their dynamics over time. We found 115 mutations estimated to be present in more than 3 % of global COVID-19 cases and determined three types of mutation dynamics: High-Frequency, Medium-Frequency, and Low-Frequency. Classification of mutations based on temporal dynamics enable us to examine viral adaptation and evaluate the effects of implemented control measures in virus evolution during the pandemic. We showed that Medium-Frequency mutations are characterized by high prevalence in specific regions and/or in constant competition with other mutations in several regions. Finally, taking N501Y mutation as representative of High-Frequency mutations, we showed that level of control measure stringency negatively correlates with the effective reproduction number of SARS-CoV-2 with High-Frequency or not-High-Frequency and both follows similar trends in different levels of stringency.
Open AccessDynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and High-Frequency mutation N501Y in different levels of control measures
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease has spread globally, causing more than 161.5 million cases and 3.3 million deaths to date. Surveillance and monitoring of new mutations in the virus’ genome are crucial to our understanding of the adaptation of SARS-CoV-2. Moreover, how the temporal dynamics of these mutations is influenced by control measures and non-pharmaceutical interventions (NPIs) is poorly understood. Using 1 058 020 SARS-CoV-2 from sequenced COVID-19 cases from 98 countries (totaling 714 country-month combinations), we perform a normalization by COVID-19 cases to calculate the relative frequency of SARS-CoV-2 mutations and explore their dynamics over time. We found 115 mutations estimated to be present in more than 3 % of global COVID-19 cases and determined three types of mutation dynamics: High-Frequency, Medium-Frequency, and Low-Frequency. Classification of mutations based on temporal dynamics enable us to examine viral adaptation and evaluate the effects of implemented control measures in virus evolution during the pandemic. We showed that Medium-Frequency mutations are characterized by high prevalence in specific regions and/or in constant competition with other mutations in several regions. Finally, taking N501Y mutation as representative of High-Frequency mutations, we showed that level of control measure stringency negatively correlates with the effective reproduction number of SARS-CoV-2 with High-Frequency or not-High-Frequency and both follows similar trends in different levels of stringency.
- Open Access
Global Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases during the Pandemic
Since the identification of SARS-CoV-2, a large number of genomes have been sequenced with unprecedented speed around the world. This marks a unique opportunity to analyze virus spreading and evolution in a worldwide context. Currently, there is not a useful haplotype description to help to track important and globally scattered mutations. Also, differences in the number of sequenced genomes between countries and/or months make it difficult to identify the emergence of haplotypes in regions where few genomes are sequenced but a large number of cases are reported. We propose an approach based on the normalization by COVID-19 cases of relative frequencies of mutations using all the available data to identify major haplotypes. Furthermore, we can use a similar normalization approach to tracking the temporal and geographic distribution of haplotypes in the world. Using 171 461 genomes, we identify five major haplotypes (OTUs) based on nine high-frequency mutations. OTU_3 characterized by mutations R203K and G204R is currently the most frequent haplotype circulating in four of the six continents analyzed. On the other hand, during almost all months analyzed, OTU_5 characterized by the mutation T85I in nsp2 is the most frequent in North America. Recently (since September), OTU_2 has been established as the most frequent in Europe. OTU_1, the ancestor haplotype is near to extinction showed by its low number of isolations since May. Also, we analyzed whether age, gender, or patient status is more related to a specific OTU. We did not find OTU’s preference for any age group, gender, or patient status. Finally, we discuss structural and functional hypotheses in the most frequently identified mutations, none of those mutations show a clear effect on the transmissibility or pathogenicity.
Open AccessGlobal Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases during the Pandemic
Since the identification of SARS-CoV-2, a large number of genomes have been sequenced with unprecedented speed around the world. This marks a unique opportunity to analyze virus spreading and evolution in a worldwide context. Currently, there is not a useful haplotype description to help to track important and globally scattered mutations. Also, differences in the number of sequenced genomes between countries and/or months make it difficult to identify the emergence of haplotypes in regions where few genomes are sequenced but a large number of cases are reported. We propose an approach based on the normalization by COVID-19 cases of relative frequencies of mutations using all the available data to identify major haplotypes. Furthermore, we can use a similar normalization approach to tracking the temporal and geographic distribution of haplotypes in the world. Using 171 461 genomes, we identify five major haplotypes (OTUs) based on nine high-frequency mutations. OTU_3 characterized by mutations R203K and G204R is currently the most frequent haplotype circulating in four of the six continents analyzed. On the other hand, during almost all months analyzed, OTU_5 characterized by the mutation T85I in nsp2 is the most frequent in North America. Recently (since September), OTU_2 has been established as the most frequent in Europe. OTU_1, the ancestor haplotype is near to extinction showed by its low number of isolations since May. Also, we analyzed whether age, gender, or patient status is more related to a specific OTU. We did not find OTU’s preference for any age group, gender, or patient status. Finally, we discuss structural and functional hypotheses in the most frequently identified mutations, none of those mutations show a clear effect on the transmissibility or pathogenicity.
- Open Access
- 26 February 2014
- Published by Universidad Nacional Federico Villarreal in The Biologist
- Vol. 12 (2) , 305-311
EFECTO DEL ACETATO DE PLOMO SOBRE LA HIPERACTIVACIÓN IN VITRO DE ESPERMATOZOIDES HUMANOS
El objetivo del presente estudio fue evaluar el efecto del acetato de plomo Pb(CH COO) sobre la 3 2 hiperactivación espermática in vitro en espermatozoides humanos. En este estudio prospectivo, se midieron los parámetros del esperma, tales como la concentración de los espermatozoides, motilidad, viabilidad y morfología de acuerdo con los criterios de la OMS. Además de estos parámetros estándar, se observó el efecto del acetato de plomo utilizando tres concentraciones -1 -1 -1(0.6µg.dL ; 6µg.dL y 66µg.dL ) sobre la hiperactivación in vitro de espermatozoides humanos. Los resultados muestran una disminución de la vitalidad, dando una CL para espermatozoides 50 -1 no hiperactivados igual a 5.58µg.dL y para el caso de espermatozoides hiperactivados fue de -1196.16 µg.dL , dando los valores de NOEC y LOEC para el porcentaje de mortalidad y -1 -1porcentaje de motilidad para ambos casos fueron de 0.6µg.dL y 6µg.dL , respectivamente. En conclusión estos hallazgos sugieren que los espermatozoides son buenos bioindicadores frente a la contaminación por Pb(CH3COO) y que este tiene efectos tóxicos sobre la motilidad y 2 vitalidad de los espermatozoides humanos.
- 26 February 2014
- Published by Universidad Nacional Federico Villarreal in The Biologist
- Vol. 12 (2) , 305-311
Open AccessEFECTO DEL ACETATO DE PLOMO SOBRE LA HIPERACTIVACIÓN IN VITRO DE ESPERMATOZOIDES HUMANOS
El objetivo del presente estudio fue evaluar el efecto del acetato de plomo Pb(CH COO) sobre la 3 2 hiperactivación espermática in vitro en espermatozoides humanos. En este estudio prospectivo, se midieron los parámetros del esperma, tales como la concentración de los espermatozoides, motilidad, viabilidad y morfología de acuerdo con los criterios de la OMS. Además de estos parámetros estándar, se observó el efecto del acetato de plomo utilizando tres concentraciones -1 -1 -1(0.6µg.dL ; 6µg.dL y 66µg.dL ) sobre la hiperactivación in vitro de espermatozoides humanos. Los resultados muestran una disminución de la vitalidad, dando una CL para espermatozoides 50 -1 no hiperactivados igual a 5.58µg.dL y para el caso de espermatozoides hiperactivados fue de -1196.16 µg.dL , dando los valores de NOEC y LOEC para el porcentaje de mortalidad y -1 -1porcentaje de motilidad para ambos casos fueron de 0.6µg.dL y 6µg.dL , respectivamente. En conclusión estos hallazgos sugieren que los espermatozoides son buenos bioindicadores frente a la contaminación por Pb(CH3COO) y que este tiene efectos tóxicos sobre la motilidad y 2 vitalidad de los espermatozoides humanos.